Monitoring of Immune and Microbial Reconstitution in (HCT) and Novel Immunotherapies
This protocol serves as a mechanism to collect, store, and distribute bodily fluid and tissue samples obtained from Hematopoietic Cell Transplant (HCT) or novel immunotherapy patients and their donors at the Masonic Cancer Center in order to conduct correlative studies of the immune system, microbiota, and their interactions. Fluid (including but not limited to, blood, urine, saliva, cerebrospinal fluid, bronchoalveolar lavage fluid) sample log-in, processing, relabeling, and storage is performed by the Masonic Cancer Center (MCC) Translational Therapy Lab (TTL).
Checked against the public recordLast updated Aug 21, 2023 · Source: ClinicalTrials.gov
What this study is about
- Purpose
- Not specified
- Study type
- Observational
- Phase
- Not applicable
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Interventions being studied
- Diagnostic Test: Blood Sample; Diagnostic Test: Stool Sample; Diagnostic Test: Urine Sample; Diagnostic Test: Bronchoalveolar Lavage (BAL) fluid; Diagnostic Test: Gastrointestinal biopsy x 2-4; Diagnostic Test: Skin biopsy; Diagnostic Test: Skin, mouth, and/or ocular swab; Diagnostic Test: Apheresis Product; Diagnostic Test: Final cellular product
How this study is categorized
These labels come from structured fields and exact terms in the public record.
Who may be able to participate
Inclusion Criteria: * Patients planning to undergo HCT or other cellular therapy/immunotherapy * Allogeneic related donors * Aged 0-80 * Willing and able to sign voluntary written consent Exclusion Criteria: * Patients whose medical record indicates that they have opted out of research
Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.
U.S. locations
- University of Minnesota Masonic Cancer CenterMinneapolis, Minnesota
Source and freshness
Processed from ClinicalTrials.gov. Last public update: Aug 21, 2023. Always confirm current availability with the study team.